{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:07:10Z","timestamp":1792606030814,"version":"4.5.0"},"reference-count":280,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Colorectal cancer (CRC) is one of the leading causes of cancer-related morbidity and mortality, with inflammation playing a pivotal role in its pathogenesis. Chronic inflammation in the intestine significantly increases the risk of CRC development. Main compounds participating in the inflammatory process are prostaglandins; bioactive lipids derived from arachidonic acid metabolism via the cyclooxygenase (COX) pathway. While it is well known that prostaglandin E2 (PGE2) promotes CRC tumorigenesis, other prostaglandins, such as PGD2, PGF2\u03b1, and prostacyclin (PGI2), remain relatively underexplored. These prostaglandins may exert distinct or opposing effects on CRC development, but the current understanding of their functions is limited. Additionally, the impact of prostaglandins on immune regulation and the tumor microenvironment, is far from being fully understood. Addressing these knowledge gaps is crucial for identifying novel therapeutic targets and optimizing chemoprevention strategies. Non-steroidal anti-inflammatory drugs (NSAIDs) have been shown to reduce the risk of CRC, largely by inhibiting prostaglandin producing enzymes. However, their use is limited due to their gastrointestinal and cardiovascular side effects. Therefore, understanding the intricate role of inflammation and prostaglandin signaling in CRC is critical to develop safer and more effective chemopreventive approaches. This review summarizes the current knowledge of prostaglandins, linking inflammation and CRC. It further addresses the potential of targeting prostaglandin pathways for chemoprevention. Furthermore, we discuss emerging pharmacological targets that modulate prostaglandin production, signaling or degradation, offering promise for preventing CRC development.<\/jats:p>","DOI":"10.3390\/ijms262412191","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T08:26:36Z","timestamp":1766132796000},"page":"12191","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The Role of Prostaglandins as Major Inflammatory Mediators in Colorectal Cancer"],"prefix":"10.3390","volume":"26","author":[{"given":"Mario","family":"Macia Guardado","sequence":"first","affiliation":[{"name":"Center of Pathobiochemistry and Genetics, Institute of Medical Genetics, Medical University of Vienna, Waehringer Strasse 10, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Lutz","sequence":"additional","affiliation":[{"name":"Center of Pathobiochemistry and Genetics, Institute of Medical Genetics, Medical University of Vienna, Waehringer Strasse 10, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Hengstschl\u00e4ger","sequence":"additional","affiliation":[{"name":"Center of Pathobiochemistry and Genetics, Institute of Medical Genetics, Medical University of Vienna, Waehringer Strasse 10, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6063-3585","authenticated-orcid":false,"given":"Helmut","family":"Dolznig","sequence":"additional","affiliation":[{"name":"Center of Pathobiochemistry and Genetics, Institute of Medical Genetics, Medical University of Vienna, Waehringer Strasse 10, 1090 Vienna, Austria"},{"name":"Comprehensive Cancer Center (CCC) Vienna, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global Cancer Statistics 2022: GLOBOCAN Estimates of incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1001\/jama.2016.13849","article-title":"Colorectal Cancer Screening","volume":"316","author":"Pinsky","year":"2016","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.7150\/ijbs.64077","article-title":"Immunotherapy in Colorectal Cancer: Current Achievements and Future Perspective","volume":"17","author":"Fan","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jama.293.2.172","article-title":"Meat Consumption and Risk of Colorectal Cancer","volume":"293","author":"Chao","year":"2005","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/1055-9965.EPI-14-1309","article-title":"Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk","volume":"24","author":"Thrift","year":"2015","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_6","first-page":"1207","article-title":"Meta-Analyses of Colorectal Cancer Risk Factors","volume":"24","author":"Johnson","year":"2013","journal-title":"Cancer Causes Control"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1093\/annonc\/mdq653","article-title":"Alcohol Drinking and Colorectal Cancer Risk: An Overall and Dose-Response Meta-Analysis of Published Studies","volume":"22","author":"Fedirko","year":"2011","journal-title":"Ann. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"682\u2013688.e1\u20135","DOI":"10.1016\/j.cgh.2009.02.016","article-title":"Cigarette Smoking and the Risk of Colorectal Cancer: A-Analysis of Prospective Cohort Studies","volume":"7","author":"Tsoi","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal Cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/1878-0261.12417","article-title":"Early-Onset Colorectal Cancer in Young Individuals","volume":"13","author":"Mauri","year":"2019","journal-title":"Mol. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/jnci\/djs346","article-title":"Contribution of Behavioral Risk Factors and Obesity to Socioeconomic Differences in Colorectal Cancer Incidence","volume":"104","author":"Doubeni","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1136\/gutjnl-2018-316191","article-title":"Evolutionary History of Human Colitis-Associated Colorectal Cancer","volume":"68","author":"Baker","year":"2019","journal-title":"Gut"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and Cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and Tumor Progression: Signaling Pathways and targeted Intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13045-024-01528-7","article-title":"Targeting Inflammation as Cancer Therapy","volume":"17","author":"Wang","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/aam.aam_56_18","article-title":"Inflammation and Cancer","volume":"18","author":"Singh","year":"2019","journal-title":"Ann. Afr. Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Kartikasari, A.E.R., Huertas, C.S., Mitchell, A., and Plebanski, M. (2021). Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.692142"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Gupta, S.C., Kunnumakkara, A.B., Aggarwal, S., and Aggarwal, B.B. (2018). Inflammation, a Double-Edge Sword for Cancer and Other Age-Related Diseases. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02160"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/emmm.201202382","article-title":"Resolution of Inflammation: An Integrated View","volume":"5","author":"Perretti","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","article-title":"Toll-like Receptors and the Control of Immunity","volume":"180","author":"Fitzgerald","year":"2020","journal-title":"Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1172\/JCI30587","article-title":"The Fundamental Basis of Inflammatory Bowel Disease","volume":"117","author":"Strober","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","article-title":"DAMP-Sensing Receptors in Sterile Inflammation and inflammatory Diseases","volume":"20","author":"Gong","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.clinthera.2016.02.028","article-title":"Key Role of DAMP in Inflammation, Cancer, and Tissue Repair","volume":"38","author":"Pandolfi","year":"2016","journal-title":"Clin. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10753-021-01615-8","article-title":"Regulatory Role of Nitric Oxide in Cutaneous Inflammation","volume":"45","author":"Man","year":"2022","journal-title":"Inflammation"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Kumar, S., and Dikshit, M. (2019). Metabolic Insight of Neutrophils in Health and Disease. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02099"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1524-475X.2008.00410.x","article-title":"Growth Factors and Cytokines in Wound Healing","volume":"16","author":"Barrientos","year":"2008","journal-title":"Wound Repair Regen."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.12968\/bjcn.2012.17.Sup3.S17","article-title":"Understanding the Inflammatory Process in Wound Healing","volume":"17","author":"Gethin","year":"2012","journal-title":"Br. J. Community Nurs."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1631\/jzus.2005.B1045","article-title":"Acute Phase Reaction and Acute Phase Proteins","volume":"6","author":"Gruys","year":"2005","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMra0910283","article-title":"Hypoxia and Inflammation","volume":"364","author":"Eltzschig","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41392-024-02049-y","article-title":"Neutrophil Diversity and Function in Health and Disease","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1182\/blood.2021012295","article-title":"Neutrophils in Acute Inflammation: Current Concepts and translational Implications","volume":"139","author":"Margraf","year":"2022","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000284367","article-title":"Neutrophil Apoptosis: Relevance to the Innate Immune response and Inflammatory Disease","volume":"2","author":"Fox","year":"2010","journal-title":"J. Innate Immun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1096\/fj.08-121228","article-title":"Macrophage Phagocytosis of Apoptotic Neutrophils Is Critically by the Opposing Actions of Pro-Inflammatory and anti-Inflammatory Agents: Key Role for TNF-Alpha","volume":"23","author":"Michlewska","year":"2009","journal-title":"FASEB J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in Inflammation: Emergence of the pro-Resolving of Mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and Inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejphar.2017.12.005","article-title":"Prostaglandin D2 Generation from Human Lung Mast Cells Is Exclusively by Cyclooxygenase-1","volume":"819","author":"Baothman","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"926968","DOI":"10.1155\/2012\/926968","article-title":"PGI2 as a Regulator of Inflammatory Diseases","volume":"2012","author":"Dorris","year":"2012","journal-title":"Mediators Inflamm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0163-7827(00)00008-4","article-title":"Distribution and Function of Prostanoid Receptors: Studies from knockout Mice","volume":"39","author":"Sugimoto","year":"2000","journal-title":"Prog. Lipid Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1172\/JCI200113416","article-title":"Mixed Messages: Modulation of Inflammation and Immune responses by Prostaglandins and Thromboxanes","volume":"108","author":"Tilley","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"966","DOI":"10.4049\/jimmunol.176.2.966","article-title":"Prostaglandin E2 Is Generally Required for Human Dendritic Migration and Exerts Its Effect via EP2 and EP4","volume":"176","author":"Legler","year":"2006","journal-title":"J. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2008.01.001","article-title":"Thromboxane A2: Physiology\/Pathophysiology, Cellular Signal and Pharmacology","volume":"118","author":"Nakahata","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0006-2952(99)00158-6","article-title":"Cyclooxygenase Knockout Mice","volume":"58","author":"Langenbach","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Abudukelimu, A., Barberis, M., Redegeld, F.A., Sahin, N., and Westerhoff, H. (2018). V Predictable Irreversible Switching between Acute and Chronic. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01596"},{"key":"ref_45","unstructured":"Pahwa, R., Goyal, A., and Jialal, I. (2025). Chronic Inflammation. StatPearls, StatPearls Publishing."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"969","DOI":"10.18632\/oncotarget.22867","article-title":"Genomic Landscape of Colitis-Associated Cancer Indicates the Impact of Chronic Inflammation and Its Stratification by Mutations in the Wnt Signaling","volume":"9","author":"Fujita","year":"2018","journal-title":"Oncotarget"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00018-013-1381-6","article-title":"TNF-Induced Necroptosis and PARP-1-Mediated Necrosis Represent Distinct Routes to Programmed Necrotic Cell Death","volume":"71","author":"Sosna","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Chiurchi\u00f9, V., Leuti, A., and Maccarrone, M. (2018). Bioactive Lipids and Chronic Inflammation: Managing the Fire. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00038"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.addr.2020.06.028","article-title":"Bioactive Lipids, Inflammation and Chronic Diseases","volume":"159","author":"Leuti","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1046\/j.1524-475X.1996.40404.x","article-title":"Interactions of Cytokines, Growth Factors, and Proteases in acute and Chronic Wounds","volume":"4","author":"Mast","year":"1996","journal-title":"Wound Repair Regen."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/01.ASW.0000416006.55218.d0","article-title":"Acute and Impaired Wound Healing","volume":"25","author":"Hamblin","year":"2012","journal-title":"Adv. Skin Wound Care"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1172\/JCI93563","article-title":"Resolution of Organ Fibrosis","volume":"128","author":"Jun","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in Tissue Repair, Regeneration, and Fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41577-021-00540-z","article-title":"Fibroblasts as Immune Regulators in Infection, Inflammation And","volume":"21","author":"Davidson","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis\u2014A Common Pathway to Organ Injury and Failure","volume":"372","author":"Rockey","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"752","DOI":"10.12688\/f1000research.8190.1","article-title":"The Myofibroblast in Wound Healing and Fibrosis: Answered and Unanswered Questions","volume":"5","author":"Gabbiani","year":"2016","journal-title":"F1000Research"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic Disease and the T(H)1\/T(H)2 Paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of Fibrosis: Therapeutic Translation for Fibrotic","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0030-1255354","article-title":"Macrophages: Master Regulators of Inflammation and Fibrosis","volume":"30","author":"Wynn","year":"2010","journal-title":"Semin. Liver Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/ecco-jcc\/jjz132","article-title":"Neutrophil Extracellular Traps Induce Intestinal Damage and thrombotic Tendency in Inflammatory Bowel Disease","volume":"14","author":"Li","year":"2020","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Yamamoto-Furusho, J.K., and Mendieta-Escalante, E.A. (2020). Diagnostic Utility of the Neutrophil-Platelet Ratio as a Novel of Activity in Patients with Ulcerative Colitis. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0231988"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2795090","DOI":"10.1155\/2016\/2795090","article-title":"The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human","volume":"2016","author":"Tan","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and Cancer: Triggers, Mechanisms, and Consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"a028662","DOI":"10.1101\/cshperspect.a028662","article-title":"Cancer Inflammation and Cytokines","volume":"10","author":"Galdiero","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s11427-017-9047-4","article-title":"Prevention and Treatment of Cancer Targeting Chronic Inflammation: Research Progress, Potential Agents, Clinical Studies and Mechanisms","volume":"60","author":"Zhang","year":"2017","journal-title":"Sci. China Life Sci."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Qu, X., Tang, Y., and Hua, S. (2018). Immunological Approaches towards Cancer and Inflammation: A Cross Talk. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00563"},{"key":"ref_67","first-page":"65","article-title":"Inflammation-Related Carcinogenesis: Current Findings in Epidemiological Trends, Causes and Mechanisms","volume":"57","author":"Okada","year":"2014","journal-title":"Yonago Acta Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/01635581.2018.1446091","article-title":"Mechanisms of Phytonutrient Modulation of Cyclooxygenase-2 (COX-2) and Inflammation Related to Cancer","volume":"70","author":"Desai","year":"2018","journal-title":"Nutr. Cancer"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Tsukamoto, T., Nakagawa, M., Kiriyama, Y., Toyoda, T., and Cao, X. (2017). Prevention of Gastric Cancer: Eradication of Helicobacter Pylori and Beyond. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18081699"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Stroffolini, T., and Stroffolini, G. (2023). A Historical Overview on the Role of Hepatitis B and C Viruses as Aetiological Factors for Hepatocellular Carcinoma. Cancers, 15.","DOI":"10.3390\/cancers15082388"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10151-019-1926-2","article-title":"Colorectal Cancer in Inflammatory Bowel Disease: Review of the Evidence","volume":"23","author":"Keller","year":"2019","journal-title":"Tech. Coloproctology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1038\/s41423-021-00726-4","article-title":"Dendritic Cell Migration in Inflammation and Immunity","volume":"18","author":"Liu","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.gendis.2021.09.006","article-title":"Inflammation and Cancer: Paradoxical Roles in Tumorigenesis and Implications in Immunotherapies","volume":"10","author":"Liu","year":"2023","journal-title":"Genes Dis."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Pei, J., Gao, Y., and Wu, A. (2024). An Inflammation-Related Subtype Classification for Analyzing Microenvironment and Clinical Prognosis in Colorectal. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1369726"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/carcin\/bgn229","article-title":"Western-Style Diet-Induced Colonic Tumors and Their Modulation by Calcium and Vitamin D in C57Bl\/6 Mice: A Preclinical Model for Human Sporadic Colon Cancer","volume":"30","author":"Newmark","year":"2009","journal-title":"Carcinogenesis"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature10209","article-title":"Genetics and Pathogenesis of Inflammatory Bowel Disease","volume":"474","author":"Khor","year":"2011","journal-title":"Nature"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MIB.0b013e31828029c0","article-title":"Declining Risk of Colorectal Cancer in Inflammatory Bowel Disease: An Updated Meta-Analysis of Population-Based Cohort Studies","volume":"19","author":"Lutgens","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2013.12.030","article-title":"Serum Inflammatory Markers and Risk of Colorectal Cancer in Patients with Inflammatory Bowel Diseases","volume":"12","author":"Ananthakrishnan","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1084\/jem.20082683","article-title":"STAT3 Links IL-22 Signaling in Intestinal Epithelial Cells to Mucosal Wound Healing","volume":"206","author":"Pickert","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1053\/j.gastro.2010.05.040","article-title":"Imbalance of NKp44+NKp46\u2212 and NKp44\u2212NKp46+ Natural Killer Cells in the Intestinal Mucosa of Patients with Crohn\u2019s Disease","volume":"139","author":"Takayama","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ni.2002","article-title":"ROR\u03b3t+ Innate Lymphoid Cells Regulate Intestinal Homeostasis by Integrating Negative Signals from the Symbiotic Microbiota","volume":"12","author":"Sawa","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/ijc.25562","article-title":"Interleukin-8 Is Associated with Proliferation, Migration, Angiogenesis and Chemosensitivity In Vitro and In Vivo in Colon Cancer Cell Line Models","volume":"128","author":"Ning","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1053\/j.gastro.2011.01.057","article-title":"Intestinal Inflammation and Cancer","volume":"140","author":"Ullman","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41577-021-00534-x","article-title":"The Inflammatory Pathogenesis of Colorectal Cancer","volume":"21","author":"Schmitt","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1053\/j.gastro.2010.01.058","article-title":"Inflammation and Colon Cancer","volume":"138","author":"Grivennikov","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1053\/j.gastro.2021.09.059","article-title":"Cyclooxygenases and Prostaglandins in Tumor Immunology and Microenvironment of Gastrointestinal Cancer","volume":"161","author":"Wang","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Jara-Guti\u00e9rrez, \u00c1., and Baladr\u00f3n, V. (2021). The Role of Prostaglandins in Different Types of Cancer. Cells, 10.","DOI":"10.3390\/cells10061487"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1289\/ehp.1002635","article-title":"Many Putative Endocrine Disruptors Inhibit Prostaglandin Synthesis","volume":"119","author":"Kristensen","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2605.1985.tb00816.x","article-title":"On the Origin of Prostaglandins in Human Seminal Fluid","volume":"8","author":"Bendvold","year":"1985","journal-title":"Int. J. Androl."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"108176","DOI":"10.1016\/j.intimp.2021.108176","article-title":"Recent Advances in Studies of 15-PGDH as a Key Enzyme for the degradation of Prostaglandins","volume":"101","author":"Sun","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1158\/0008-5472.CAN-21-2297","article-title":"Prostaglandin Pathways: Opportunities for Cancer Prevention and Therapy","volume":"82","author":"Wang","year":"2022","journal-title":"Cancer Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/eji.202048909","article-title":"Prostaglandin Regulation of Type 2 Inflammation: From Basic Biology to Therapeutic Interventions","volume":"51","author":"Oyesola","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/pr.56.3.3","article-title":"Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition","volume":"56","author":"Simmons","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Khan, S.A., and Ilies, M.A. (2023). The Phospholipase A2 Superfamily: Structure, Isozymes, Catalysis, Physiologic and Pathologic Roles. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021353"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.3748\/wjg.v24.i48.5454","article-title":"Post-Translational Modifications of Prostaglandin-Endoperoxide Synthase 2 in Colorectal Cancer: An Update","volume":"24","author":"Prieto","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e0003","DOI":"10.5041\/RMMJ.10426","article-title":"Different Chemical Structures and Physiological\/Pathological of Cyclooxygenases","volume":"12","author":"Faki","year":"2021","journal-title":"Rambam Maimonides Med. J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1042\/EBC20190082","article-title":"Oxidation of Polyunsaturated Fatty Acids to Produce Lipid Mediators","volume":"64","author":"Christie","year":"2020","journal-title":"Essays Biochem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1152\/physiolgenomics.00086.2017","article-title":"Cyclooxygenase 2: Protein-Protein Interactions and Posttranslational Modifications","volume":"49","author":"Alexanian","year":"2017","journal-title":"Physiol. Genom."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.plipres.2017.04.003","article-title":"Prostaglandin Synthases: Molecular Characterization and Involvement in Prostaglandin Biosynthesis","volume":"66","author":"Seo","year":"2017","journal-title":"Prog. Lipid Res."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Hidalgo-Est\u00e9vez, A.M., Stamatakis, K., Jim\u00e9nez-Mart\u00ednez, M., L\u00f3pez-P\u00e9rez, R., and Fresno, M. (2020). Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00533"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"7220","DOI":"10.1073\/pnas.96.13.7220","article-title":"Identification of Human Prostaglandin E Synthase: A Microsomal, Glutathione-Dependent, Inducible Enzyme, Constituting a Potential Novel Drug Target","volume":"96","author":"Jakobsson","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1046-5928(02)00566-1","article-title":"Purification and Characterization of Recombinant Microsomal Prostaglandin E Synthase-1","volume":"26","author":"Ouellet","year":"2002","journal-title":"Protein Expr. Purif."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.plefa.2003.04.002","article-title":"Prostaglandin Synthases: Recent Developments and a Novel Hypothesis","volume":"70","author":"Helliwell","year":"2004","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.semarthrit.2006.03.005","article-title":"Prostaglandins in Health and Disease: An Overview","volume":"36","author":"Miller","year":"2006","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_105","first-page":"248","article-title":"The Prostaglandin Transporter: Eicosanoid Reuptake, Control of signaling, and Development of High-Affinity Inhibitors as Drug","volume":"126","author":"Schuster","year":"2015","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"107803","DOI":"10.1016\/j.pharmthera.2021.107803","article-title":"Recent Advances in Studies of SLCO2A1 as a Key Regulator of the Delivery of Prostaglandins to Their Sites of Action","volume":"223","author":"Nakanishi","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/EBC20190083","article-title":"Eicosanoids","volume":"64","author":"Calder","year":"2020","journal-title":"Essays Biochem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI200113455","article-title":"Genetic and Pharmacological Analysis of Prostanoid Receptor Function","volume":"108","author":"Narumiya","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"De Paz Linares, G.A., Opperman, R.M., Majumder, M., and Lala, P.K. (2021). Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis. Cancers, 13.","DOI":"10.3390\/cancers13050942"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.drudis.2016.08.003","article-title":"Structural Features of Subtype-Selective EP Receptor Modulators","volume":"22","author":"Jakopin","year":"2017","journal-title":"Drug Discov. Today"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1074\/jbc.R600038200","article-title":"Prostaglandin E Receptors","volume":"282","author":"Sugimoto","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.cardiores.2005.12.020","article-title":"Prostanoid Signal Transduction and Gene Expression in the Endothelium: Role in Cardiovascular Diseases","volume":"70","author":"Alfranca","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bbalip.2009.01.021","article-title":"EP(3) Prostanoid Receptor Isoforms Utilize Distinct mechanisms to Regulate ERK 1\/2 Activation","volume":"1791","author":"Israel","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_114","first-page":"4702","article-title":"Prostaglandin E2 Receptor EP4 Is Involved in the Cell Growth and Invasion of Prostate Cancer via the cAMP-PKA\/PI3K-Akt Signaling Pathway","volume":"17","author":"Xu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.pharmthera.2013.03.006","article-title":"E-Type Prostanoid Receptor 4 (EP4) in Disease and Therapy","volume":"138","author":"Konya","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1124\/mol.65.4.973","article-title":"The Two-Step Model of Prostaglandin Signal Termination: In Vitro Reconstitution with the Prostaglandin Transporter and Prostaglandin 15 Dehydrogenase","volume":"65","author":"Nomura","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41467-018-08097-7","article-title":"Prostaglandin E2 Mediates Sensory Nerve Regulation of Bone Homeostasis","volume":"10","author":"Chen","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/jb\/mvr116","article-title":"Recent Reports about Enzymes Related to the Synthesis of Prostaglandin (PG) F2 (PGF2\u03b1 and 9\u03b1, 11\u03b2-PGF2)","volume":"150","author":"Watanabe","year":"2011","journal-title":"J. Biochem."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"26586","DOI":"10.18632\/oncotarget.25005","article-title":"Prostaglandins in the Pathogenesis of Kidney Diseases","volume":"9","author":"Li","year":"2018","journal-title":"Oncotarget"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1345\/aph.1A178","article-title":"Prostaglandin Analog Treatment of Glaucoma and Ocular Hypertension","volume":"36","author":"Alexander","year":"2002","journal-title":"Ann. Pharmacother."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jb\/mvn152","article-title":"Prostaglandin F2\u03b1 Synthase Activities of Aldo-Keto Reductase 1B1, 1B3 and 1B7","volume":"145","author":"Kabututu","year":"2009","journal-title":"J. Biochem."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1080\/13543776.2017.1379503","article-title":"Aldo-Keto Reductase (AKR) 1C3 Inhibitors: A Patent Review","volume":"27","author":"Penning","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/ijc.22755","article-title":"Prostaglandin F2\u03b1 Stimulates Motility and Invasion in Colorectal Tumor Cells","volume":"121","author":"Qualtrough","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/j.1476-5381.2009.00464.x","article-title":"Cyclic AMP-Mediated Chloride Secretion Is Induced by Prostaglandin F2alpha in Human Isolated Colon","volume":"158","author":"Collins","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/oxfordjournals.jbchem.a022211","article-title":"Identification of a Principal mRNA Species for Human 3alpha-Hydroxysteroid Dehydrogenase Isoform (AKR1C3) That Exhibits High Prostaglandin D2 11-Ketoreductase Activity","volume":"124","author":"Matsuura","year":"1998","journal-title":"J. Biochem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1530\/REP-07-0514","article-title":"Two Pathways for Prostaglandin F2 Alpha Synthesis by the Primate Periovulatory Follicle","volume":"136","author":"Dozier","year":"2008","journal-title":"J. Reprod. Fertil."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1084\/jem.20160459","article-title":"PKA Regulatory II\u03b1 Subunit Is Essential for PGD2-Mediated Resolution of Inflammation","volume":"213","author":"Kong","year":"2016","journal-title":"J. Exp. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"20979","DOI":"10.1073\/pnas.0707394104","article-title":"Hematopoietic Prostaglandin D2 Synthase Controls the Onset and Resolution of Acute Inflammation through PGD2 and 15-DeoxyDelta12 14 PGJ2","volume":"104","author":"Rajakariar","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrd2266","article-title":"Antagonism of the Prostaglandin D2 Receptors DP1 and CRTH2 as an Approach to Treat Allergic Diseases","volume":"6","author":"Pettipher","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Rittchen, S., and Heinemann, A. (2019). Therapeutic Potential of Hematopoietic Prostaglandin D2 Synthase in Allergic Inflammation. Cells, 8.","DOI":"10.3390\/cells8060619"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1034\/j.1600-0897.2002.01113.x","article-title":"Prostaglandin D2 and Reproduction","volume":"47","author":"Saito","year":"2002","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.smrv.2011.08.003","article-title":"Prostaglandin D2 and Sleep\/Wake Regulation","volume":"15","author":"Urade","year":"2011","journal-title":"Sleep Med. Rev."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1073\/pnas.96.2.726","article-title":"Lack of Tactile Pain (Allodynia) in Lipocalin-Type Prostaglandin D Synthase-Deficient Mice","volume":"96","author":"Eguchi","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1067\/mai.2001.119919","article-title":"Selective Modulation of Chemokinesis, Degranulation, and apoptosis in Eosinophils through the PGD2 Receptors CRTH2 and DP","volume":"108","author":"Gervais","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM198407263110401","article-title":"The Bronchoconstrictor Effect of Inhaled Prostaglandin D2 in normal and Asthmatic Men","volume":"311","author":"Hardy","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1523-1747.2002.01862.x","article-title":"Association of a New-Type Prostaglandin D2 Receptor CRTH2 with Circulating T Helper 2 Cells in Patients with Atopic","volume":"119","author":"Iwasaki","year":"2002","journal-title":"J. Investig. Dermatol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10555-011-9297-9","article-title":"The Thromboxane Synthase and Receptor Signaling Pathway in Cancer: An Emerging Paradigm in Cancer Progression and Metastasis","volume":"30","author":"Ekambaram","year":"2011","journal-title":"Cancer Metastasis Rev."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Szczuko, M., Kozio\u0142, I., Kotl\u0119ga, D., Brodowski, J., and Drozd, A. (2021). The Role of Thromboxane in the Course and Treatment of Ischemic Stroke: Review. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111644"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1472-8206.1997.tb00163.x","article-title":"Thromboxane A2 and Related Prostaglandins in Airways","volume":"11","author":"Devillier","year":"1997","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0090-6980(99)00062-3","article-title":"Thromboxane A2 Receptors: Where Have You Gone?","volume":"60","author":"Halushka","year":"2000","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/cbin.11519","article-title":"TGF-\u03b2 Acts as a Dual Regulator of COX-2\/PGE2 Tumor Promotion Depending of Its Cross-Interaction with H-Ras and Wnt\/\u03b2-Catenin Pathways in Colorectal Cancer Cells","volume":"45","author":"Tanaka","year":"2021","journal-title":"Cell Biol. Int."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"C988","DOI":"10.1152\/ajpcell.1998.275.4.C988","article-title":"Cytokine-Mediated PGE2 Expression in Human Colonic Fibroblasts","volume":"275","author":"Kim","year":"1998","journal-title":"Am. J. Physiol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1101\/gad.183434.111","article-title":"NF-\u03baB, the First Quarter-Century: Remarkable Progress and Outstanding Questions","volume":"26","author":"Hayden","year":"2012","journal-title":"Genes Dev."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Cai, T.-T., Ye, S.-B., Liu, Y.-N., He, J., Chen, Q.-Y., Mai, H.-Q., Zhang, C.-X., Cui, J., Zhang, X.-S., and Busson, P. (2017). LMP1-Mediated Glycolysis Induces Myeloid-Derived Suppressor Cell Expansion in Nasopharyngeal Carcinoma. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006503"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.chemosphere.2017.09.098","article-title":"PM2.5 Exposure Stimulates COX-2-Mediated Excitatory Synaptic Transmission via ROS-NF-\u03baB Pathway","volume":"190","author":"Li","year":"2018","journal-title":"Chemosphere"},{"key":"ref_146","first-page":"3811","article-title":"COX-2 Promotes Epithelial-mesenchymal Transition and Migration in Osteosarcoma MG-63 Cells via PI3K\/AKT\/NF-\u03baB Signaling","volume":"20","author":"Zhang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1002\/jcp.22537","article-title":"Activation and Induction of Cytosolic Phospholipase A2 by TNF-\u03b1 Mediated through Nox2, MAPKs, NF-\u03baB, and P300 in Human Tracheal Smooth Muscle Cells","volume":"226","author":"Lee","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.tranon.2018.11.010","article-title":"The Role of TGF-\u03b2 and Its Receptors in Gastrointestinal Cancers","volume":"12","author":"Luo","year":"2019","journal-title":"Transl. Oncol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1002\/jcp.26356","article-title":"V Reactive Oxygen Species and Colorectal Cancer","volume":"233","author":"Lin","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.fct.2017.05.006","article-title":"Differential Cytotoxic Activity of Quercetin on Colonic Cancer Cells Depends on ROS Generation through COX-2 Expression","volume":"106","author":"Raja","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/onc.2009.421","article-title":"The Role of COX-2 in Intestinal Inflammation and Colorectal Cancer","volume":"29","author":"Wang","year":"2010","journal-title":"Oncogene"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"6683","DOI":"10.1158\/0008-5472.CAN-06-0425","article-title":"Direct Transcriptional Up-Regulation of Cyclooxygenase-2 by Hypoxia-Inducible Factor (HIF)-1 Promotes Colorectal Tumor Cell Survival and Enhances HIF-1 Transcriptional Activity during Hypoxia","volume":"66","author":"Kaidi","year":"2006","journal-title":"Cancer Res."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1158\/0008-5472.CAN-05-1357","article-title":"Thioredoxin-1 Modulates Transcription of Cyclooxygenase-2 via Hypoxia-Inducible Factor-1\u03b1 in Non-Small Cell Lung Cancer","volume":"66","author":"Csiki","year":"2006","journal-title":"Cancer Res."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00018-011-0876-2","article-title":"NF\u03baB and HIF Display Synergistic Behaviour during Hypoxic Inflammation","volume":"69","author":"Bruning","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1074\/jbc.272.1.601","article-title":"Hypoxia Induces Cyclooxygenase-2 via the NF-KappaB P65 Transcription Factor in Human Vascular Endothelial Cells","volume":"272","author":"Schmedtje","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.ceb.2009.08.005","article-title":"Mitochondrial Reactive Oxygen Species Regulate Hypoxic Signaling","volume":"21","author":"Hamanaka","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"3907147","DOI":"10.1155\/2016\/3907147","article-title":"The Interplay of Reactive Oxygen Species, Hypoxia, Inflammation, and Sirtuins in Cancer Initiation and Progression","volume":"2016","author":"Tafani","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neo.2016.07.009","article-title":"Role of Cyclooxygenase-2 Pathway in Creating an Immunosuppressive Microenvironment and in Initiation and Progression of Wilms\u2019 Tumor","volume":"19","author":"Maturu","year":"2017","journal-title":"Neoplasia"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"7674","DOI":"10.1158\/1078-0432.CCR-05-1205","article-title":"Cyclooxygenase-2-Dependent Activation of Signal Transducer and activator of Transcription 3 by Interleukin-6 in Non-Small Cell Cancer","volume":"11","author":"Dalwadi","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.canlet.2016.12.031","article-title":"Metformin Inhibits Castration-Induced EMT in Prostate Cancer by Repressing COX2\/PGE2\/STAT3 Axis","volume":"389","author":"Tong","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.biopha.2017.12.049","article-title":"Gramine Attenuates EGFR-Mediated Inflammation and Cell Proliferation in Oral Carcinogenesis via Regulation of NF-\u03baB and STAT3 Signaling","volume":"98","author":"Ramu","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1172\/JCI97953","article-title":"Role of Prostanoids in Gastrointestinal Cancer","volume":"128","author":"Wang","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1158\/1940-6207.CAPR-21-0572","article-title":"The COX-2-PGE2 Pathway Promotes Tumor Evasion in Colorectal Adenomas","volume":"15","author":"Wei","year":"2022","journal-title":"Cancer Prev. Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3393\/ac.2021.00374.0053","article-title":"Upregulation of Prostaglandin E2 by Inducible Microsomal Prostaglandin E Synthase-1 in Colon Cancer","volume":"38","author":"Kim","year":"2022","journal-title":"Ann. Coloproctology"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2147\/JIR.S278514","article-title":"Overview on the Discovery and Development of Anti-Inflammatory Drugs: Should the Focus Be on Synthesis or Degradation of PGE2?","volume":"14","author":"Mahesh","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Tuure, L., H\u00e4m\u00e4l\u00e4inen, M., Whittle, B.J., and Moilanen, E. (2017). Microsomal Prostaglandin E Synthase-1 Expression in inflammatory Conditions Is Downregulated by Dexamethasone: Seminal Role of the Regulatory Phosphatase MKP-1. Front. Pharmacol., 8.","DOI":"10.3389\/fphar.2017.00646"},{"key":"ref_167","first-page":"3971","article-title":"Inducible Microsomal Prostaglandin E Synthase Is overexpressed in Colorectal Adenomas and Cancer","volume":"7","author":"Yoshimatsu","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1038\/onc.2011.472","article-title":"Microsomal Prostaglandin E Synthase-1 Is Involved in Multiple Steps of Colon Carcinogenesis","volume":"31","author":"Sasaki","year":"2012","journal-title":"Oncogene"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.biochi.2010.02.006","article-title":"mPGES-1 as a Target for Cancer Suppression: A Comprehensive Invited Review \u201cPhospholipase A2 and Lipid Mediators\u201d","volume":"92","author":"Nakanishi","year":"2010","journal-title":"Biochimie"},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Chaudhary, P.K., and Kim, S. (2021). An Insight into GPCR and G-Proteins as Cancer Drivers. Cells, 10.","DOI":"10.3390\/cells10123288"},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Arakaki, A.K.S., Pan, W.-A., and Trejo, J. (2018). GPCRs in Cancer: Protease-Activated Receptors, Endocytic Adaptors and Signaling. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19071886"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1111\/bph.13331","article-title":"Prostaglandin E2 and the EP Receptors in Malignancy: Possible Therapeutic Targets?","volume":"172","author":"Houston","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1388-1981(99)00164-X","article-title":"The Utilization of Recombinant Prostanoid Receptors to Determine the Affinities and Selectivities of Prostaglandins and Related Analogs","volume":"1483","author":"Abramovitz","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.0022-202X.2005.23829.x","article-title":"Differential Expression of E Prostanoid Receptors in murine and Human Non-Melanoma Skin Cancer","volume":"125","author":"Lee","year":"2005","journal-title":"J. Investig. Dermatol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ijc.22582","article-title":"EP1-4 Subtype, COX and PPAR Gamma Receptor Expression in colorectal Cancer in Prediction of Disease-Specific Mortality","volume":"121","author":"Gustafsson","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1038\/srep06538","article-title":"Prostaglandin E2 Stimulates \u03921-Integrin Expression in hepatocellular Carcinoma through the EP1\/PKC\/NF-\u039aB Pathway","volume":"4","author":"Bai","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0304-3835(00)00440-7","article-title":"Inhibitory Effect of a Prostaglandin E Receptor Subtype EP1 Antagonist, ONO-8713, on Development of azoxymethane-Induced Aberrant Crypt Foci in Mice","volume":"156","author":"Watanabe","year":"2000","journal-title":"Cancer Lett."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1349-7006.2003.tb01492.x","article-title":"Combined Effects of Prostaglandin E Receptor Subtype EP1 and subtype EP4 Antagonists on Intestinal Tumorigenesis in adenomatous Polyposis Coli Gene Knockout Mice","volume":"94","author":"Kitamura","year":"2003","journal-title":"Cancer Sci."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.jid.5700014","article-title":"Importance of the EP(1) Receptor in Cutaneous UVB-Induced and Tumor Development","volume":"126","author":"Tober","year":"2006","journal-title":"J. Investig. Dermatol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"7010","DOI":"10.1158\/0008-5472.CAN-11-1262","article-title":"ANGPTL4 Induction by Prostaglandin E2 under Hypoxic Promotes Colorectal Cancer Progression","volume":"71","author":"Kim","year":"2011","journal-title":"Cancer Res."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ijc.28076","article-title":"Targeting the EP1 Receptor Reduces Fas Ligand Expression and increases the Antitumor Immune Response in an In Vivo Model of colon Cancer","volume":"133","author":"Ryan","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/sj.bjc.6604490","article-title":"Prostaglandin E2 Stimulates Fas Ligand Expression via the EP1 Receptor in Colon Cancer Cells","volume":"99","author":"Kelly","year":"2008","journal-title":"Br. J. Cancer"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.4049\/jimmunol.0801548","article-title":"Fas Signal Promotes Lung Cancer Growth by Recruiting-Derived Suppressor Cells via Cancer Cell-Derived PGE2","volume":"182","author":"Zhang","year":"2009","journal-title":"J. Immunol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/1541-7786.MCR-10-0003","article-title":"Prostaglandin E Receptor EP1 Suppresses Breast Cancer and Is Linked to Survival Differences and Cancer","volume":"8","author":"Ma","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41232-017-0036-7","article-title":"Prostaglandin E2-EP2 Signaling as a Node of Chronic Inflammation in the Colon Tumor Microenvironment","volume":"1","author":"Aoki","year":"2017","journal-title":"Inflamm. Regen."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.1116221","article-title":"Prostaglandin E2 Promotes Colon Cancer Cell Growth through a Gs-Axin-\u03b2-Catenin Signaling Axis","volume":"310","author":"Castellone","year":"2005","journal-title":"Science"},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Hsu, H.-H., Lin, Y.-M., Shen, C.-Y., Shibu, M.A., Li, S.-Y., Chang, S.-H., Lin, C.-C., Chen, R.-J., Viswanadha, V.P., and Shih, H.-N. (2017). Prostaglandin E2-Induced COX-2 Expressions via EP2 and EP4 Pathways in Human LoVo Colon Cancer Cells. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18061132"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/sj.bjp.0706923","article-title":"Prostaglandin E2 Receptor Distribution and Function in the gastrointestinal Tract","volume":"149","author":"Dey","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1007\/s00432-020-03272-0","article-title":"Prostaglandin E2 Receptor 3 (EP3) Signaling Promotes of Cervical Cancer via Urokinase-Type Plasminogen Receptor (UPAR)","volume":"146","author":"Ye","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.2147\/OTT.S204919","article-title":"EP3 Receptor Antagonist L798,106 Reduces Proliferation and migration of SK-BR-3 Breast Cancer Cells","volume":"12","author":"Hester","year":"2019","journal-title":"Onco Targets Ther."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/j.1349-7006.2009.01322.x","article-title":"Roles of a Prostaglandin E-Type Receptor, EP3, in upregulation of Matrix Metalloproteinase-9 and Vascular Endothelial Growth during Enhancement of Tumor Metastasis","volume":"100","author":"Amano","year":"2009","journal-title":"Cancer Sci."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"31270","DOI":"10.18632\/oncotarget.16116","article-title":"PGE2\/EP3\/SRC Signaling Induces EGFR Nuclear translocation and Growth through EGFR Ligands Release in Lung Adenocarcinoma","volume":"8","author":"Bazzani","year":"2017","journal-title":"Oncotarget"},{"key":"ref_193","first-page":"5645","article-title":"Inhibition of Ep3 Attenuates Migration and Promotes Apoptosis Of-Small Cell Lung Cancer Cells via Suppression of TGF-\u03b2\/Smad Signaling","volume":"16","author":"Li","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"982","DOI":"10.18632\/oncotarget.23140","article-title":"Prostaglandin Receptor EP3 Regulates Cell Proliferation and migration with Impact on Survival of Endometrial Cancer Patients","volume":"9","author":"Zhu","year":"2018","journal-title":"Oncotarget"},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Semmlinger, A., von Schoenfeldt, V., Wolf, V., Meuter, A., Kolben, T.M., Kolben, T., Zeder-Goess, C., Weis, F., Gallwas, J., and Wuerstlein, R. (2018). EP3 (Prostaglandin E2 Receptor 3) Expression Is a Prognostic for Progression-Free and Overall Survival in Sporadic Cancer. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4286-9"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/gut.2003.028787","article-title":"Downregulation of Prostaglandin E Receptor Subtype EP3 during Colon Cancer Development","volume":"53","author":"Shoji","year":"2004","journal-title":"Gut"},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Jin, K., Qian, C., Lin, J., and Liu, B. (2023). Cyclooxygenase-2-Prostaglandin E2 Pathway: A Key Player in tumor-Associated Immune Cells. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1099811"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"9304","DOI":"10.1158\/0008-5472.CAN-05-1015","article-title":"Lack of Expression of the EP2 but Not EP3 Receptor for prostaglandin E2 Results in Suppression of Skin Tumor","volume":"65","author":"Sung","year":"2005","journal-title":"Cancer Res."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/nm0901-1048","article-title":"Acceleration of Intestinal Polyposis through Prostaglandin EP2 in Apc\u0394716 Knockout Mice","volume":"7","author":"Sonoshita","year":"2001","journal-title":"Nat. Med."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1084\/jem.20021408","article-title":"Host Prostaglandin E2-EP3 Signaling Regulates Tumor-Associated and Tumor Growth","volume":"197","author":"Amano","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Dey, I., Beck, P.L., and Chadee, K. (2013). Lymphocytic Colitis Is Associated with Increased-Inflammatory Cytokine Profile and up Regulation of prostaglandin Receptor EP4. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0061891"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ejphar.2013.08.002","article-title":"Induction of Cyclooxygenase-2 Expression by Prostaglandin E2 of the Prostanoid EP4 Receptor via Coupling to G\u03b1i and Transactivation of the Epidermal Growth Factor in HCA-7 Human Colon Cancer Cells","volume":"718","author":"Yoshida","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"153247","DOI":"10.1016\/j.prp.2020.153247","article-title":"EP4 Receptor as a Novel Promising Therapeutic Target in Colon","volume":"216","author":"Karpisheh","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.7150\/ijms.44439","article-title":"The Role of Cyclooxygenase-2 in Colorectal Cancer","volume":"17","author":"Sheng","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ebiom.2018.05.008","article-title":"Inhibition of Microsomal Prostaglandin E Synthase-1 in Cancer-Associated Fibroblasts Suppresses Neuroblastoma Tumor Growth","volume":"32","author":"Kock","year":"2018","journal-title":"EBioMedicine"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1124\/pr.110.003517","article-title":"International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress","volume":"63","author":"Woodward","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cbi.2008.10.024","article-title":"Type 5 17\u03b2-Hydroxysteroid Dehydrogenase\/Prostaglandin F (AKR1C3): Role in Breast Cancer and Inhibition by non-Steroidal Anti-Inflammatory Drug Analogs","volume":"178","author":"Byrns","year":"2009","journal-title":"Chem. Biol. Interact."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/er.2018-00089","article-title":"Structural and Functional Biology of Aldo-Keto Reductase-Transforming Enzymes","volume":"40","author":"Penning","year":"2019","journal-title":"Endocr. Rev."},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Li, M., Zhang, L., Yu, J., Wang, X., Cheng, L., Ma, Z., Chen, X., Wang, L., and Goh, B.C. (2024). AKR1C3 in Carcinomas: From Multifaceted Roles to Therapeutic. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1378292"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/cbin.11789","article-title":"ARID3A Promotes the Chemosensitivity of Colon Cancer by Inhibiting AKR1C3","volume":"46","author":"Li","year":"2022","journal-title":"Cell Biol. Int."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0090-6980(95)00154-9","article-title":"Identification of Arachidonic Acid Pathways Required for the Invasive and Metastatic Activity of Malignant Tumor Cells","volume":"51","author":"Reich","year":"1996","journal-title":"Prostaglandins"},{"key":"ref_212","first-page":"2772","article-title":"Prostaglandins Increase Matrix Metalloproteinase Release from Human Ciliary Smooth Muscle Cells","volume":"38","author":"Weinreb","year":"1997","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_213","first-page":"2","article-title":"Integrin Receptors and Extracellular Matrix Components in Parotid Neoplasms","volume":"27","author":"Charalabopoulos","year":"2005","journal-title":"Exp. Oncol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.biopha.2007.08.007","article-title":"Induction of Matrix Metalloproteinases by Epstein-Barr Virus Latent Membrane Protein 1 Isolated from Nasopharyngeal Carcinoma","volume":"61","author":"Lee","year":"2007","journal-title":"Biomed. Pharmacother."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.biopha.2008.07.094","article-title":"Acetylsalicylic Acid Regulates MMP-2 Activity and Inhibits Colorectal Invasion of Murine B16F0 Melanoma Cells in C57BL\/6J Mice: Effects of Prostaglandin F2\u03b1","volume":"63","author":"Tsai","year":"2009","journal-title":"Biomed. Pharmacother."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0300-483X(03)00077-5","article-title":"Enhancement of Carcinogen-Induced Malignant Cell Transformation by Prostaglandin F2\u03b1","volume":"188","year":"2003","journal-title":"Toxicology"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/BF02056946","article-title":"Tissue Prostaglandin Levels in Familial Adenomatous Polyposis Patients Treated with Sulindac","volume":"39","author":"Nugent","year":"1996","journal-title":"Dis. Colon Rectum"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1572-0241.2002.05427.x","article-title":"Increased Urinary F2-Isoprostanes in Patients with Crohn\u2019s Disease","volume":"97","author":"Cracowski","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Romanuik, T.L., Wang, G., Morozova, O., Delaney, A., Marra, M.A., and Sadar, M.D. (2010). LNCaP Atlas: Gene Expression Associated with in Vivo Progression to Castration-Recurrent Prostate Cancer. BMC Med. Genom., 3.","DOI":"10.1186\/1755-8794-3-43"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1176935119835522","DOI":"10.1177\/1176935119835522","article-title":"Transcriptomics Signature from Next-Generation Sequencing Data Reveals New Transcriptomic Biomarkers Related to Prostate Cancer","volume":"18","author":"Alkhateeb","year":"2019","journal-title":"Cancer Inform."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"39941","DOI":"10.18632\/oncotarget.5402","article-title":"Prostaglandins Induce Early Growth Response 1 Transcription Factor Mediated Microsomal Prostaglandin E2 Synthase Up-Regulation for Colorectal Cancer Progression","volume":"6","author":"Stamatakis","year":"2015","journal-title":"Oncotarget"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/pin.12031","article-title":"The F-Prostaglandin Receptor Is a Novel Marker for Tumor Endothelial Cells in Renal Cell Carcinoma","volume":"63","author":"Akiyama","year":"2013","journal-title":"Pathol. Int."},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Braicu, C., Buse, M., Busuioc, C., Drula, R., Gulei, D., Raduly, L., Rusu, A., Irimie, A., Atanasov, A.G., and Slaby, O. (2019). A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer. Cancers, 11.","DOI":"10.3390\/cancers11101618"},{"key":"ref_224","doi-asserted-by":"crossref","unstructured":"Marampon, F., Ciccarelli, C., and Zani, B.M. (2019). Biological Rationale for Targeting MEK\/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20102530"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1146\/annurev.pharmtox.41.1.661","article-title":"Prostanoid Receptors: Subtypes and Signaling","volume":"41","author":"Breyer","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41416-021-01595-4","article-title":"High PGD2 Receptor 2 Levels Are Associated with Poor Prognosis in Colorectal Cancer Patients and Induce VEGF Expression in Colon Cancer Cells and Migration in a Zebrafish Xenograft Model","volume":"126","author":"Dash","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2310\/JIM.0b013e31819aaa76","article-title":"The Anti-Inflammatory Effects of Prostaglandins","volume":"57","author":"Scher","year":"2009","journal-title":"J. Investig. Med."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/bjc.2017.238","article-title":"Intracrine VEGF Signalling Mediates Colorectal Cancer Cell Migration and Invasion","volume":"117","author":"Bhattacharya","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"Patrono, C., and Rocca, B. (2019). Measurement of Thromboxane Biosynthesis in Health and Disease. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.01244"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1016\/j.febslet.2006.05.007","article-title":"Upregulation of Thromboxane Synthase in Human Colorectal Carcinoma and the Cancer Cell Proliferation by Thromboxane A2","volume":"580","author":"Sakai","year":"2006","journal-title":"FEBS Lett."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ebiom.2014.12.004","article-title":"Circulating Prostaglandin Biosynthesis in Colorectal Cancer and Potential Clinical Significance","volume":"2","author":"Li","year":"2015","journal-title":"EBioMedicine"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1124\/jpet.111.190785","article-title":"Effects of Celecoxib on Prostanoid Biosynthesis and Circulating Proteins in Familial Adenomatous Polyposis","volume":"341","author":"Dovizio","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1365-2125.2011.03985.x","article-title":"TP Receptor Antagonists (TXRAs): Expensive Irrelevance or Wonder Drugs Strangled at Birth?","volume":"71","author":"Ritter","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1046\/j.1365-2249.1999.01017.x","article-title":"Effect of Shear Stress and a Stable Prostaglandin I2 Analogue on Adhesive Interactions of Colon Cancer Cells and Endothelial Cells","volume":"117","author":"Yoshida","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0006-291X(81)80128-3","article-title":"Thromboxanes and Prostacyclin: Positive and Negative Modulators of Tumor Growth","volume":"102","author":"Honn","year":"1981","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_236","first-page":"450","article-title":"V Effects of Prostacyclin on Tumor Cell-Induced Platelet Aggregation","volume":"44","author":"Menter","year":"1984","journal-title":"Cancer Res."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41389-020-00256-0","article-title":"Tumour Suppressor 15-Hydroxyprostaglandin Dehydrogenase Induces Differentiation in Colon Cancer via GLI1 Inhibition","volume":"9","author":"Satapathy","year":"2020","journal-title":"Oncogenesis"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/med.20098","article-title":"Novel Cyclooxygenase-Catalyzed Bioactive Prostaglandin F2alpha from Physiology to New Principles in Inflammation","volume":"27","author":"Basu","year":"2007","journal-title":"Med. Res. Rev."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/PPO.0000000000000003","article-title":"An Inflammatory Mediator, Prostaglandin E2, in Colorectal Cancer","volume":"19","author":"Wang","year":"2013","journal-title":"Cancer J."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.molonc.2016.07.011","article-title":"Non-Canonical WNT5A Signaling up-Regulates the Expression of the Tumor Suppressor 15-PGDH and Induces Differentiation of Colon Cancer Cells","volume":"10","author":"Mehdawi","year":"2016","journal-title":"Mol. Oncol."},{"key":"ref_241","first-page":"469","article-title":"Receptor and Enzyme Expression for Prostanoid Metabolism in Colorectal Cancer Related to Tumor Tissue PGE2","volume":"36","author":"Gustafsson","year":"2010","journal-title":"Int. J. Oncol."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"35033","DOI":"10.18632\/oncotarget.16591","article-title":"A Potential Anti-Tumor Effect of Leukotriene C4 through the Induction of 15-Hydroxyprostaglandin Dehydrogenase Expression in Colon Cancer Cells","volume":"8","author":"Mehdawi","year":"2017","journal-title":"Oncotarget"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/gutjnl-2011-300817","article-title":"B-Catenin Represses Expression of the Tumour Suppressor 15-Prostaglandin Dehydrogenase in the Normal Intestinal Epithelium and Colorectal Tumour Cells","volume":"61","author":"Smartt","year":"2012","journal-title":"Gut"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3346\/jkms.2013.28.8.1154","article-title":"15-Hydroxyprostaglandin Dehydrogenase in Colorectal Mucosa as a Potential Biomarker for Predicting Colorectal Neoplasms","volume":"28","author":"Lee","year":"2013","journal-title":"J. Korean Med. Sci."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.21873\/anticanres.16043","article-title":"15-Prostaglandin Dehydrogenase Inhibition Enhances Colon Cancer Metastasis by up-Regulation of Epithelial-to-Mesenchymal Transition Genes","volume":"42","author":"Kim","year":"2022","journal-title":"Anticancer Res."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1074\/jbc.M411221200","article-title":"15-Hydroxyprostaglandin Dehydrogenase Is Down-Regulated in Colorectal Cancer","volume":"280","author":"Backlund","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"17468","DOI":"10.1073\/pnas.0406142101","article-title":"15-Hydroxyprostaglandin Dehydrogenase, a COX-2 Oncogene Antagonist, Is a TGF-Beta-Induced Suppressor of Human Gastrointestinal Cancers","volume":"101","author":"Yan","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Lepore Signorile, M., Grossi, V., Fasano, C., and Simone, C. (2023). Colorectal Cancer Chemoprevention: A Dream Coming True?. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087597"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1158\/1940-6207.CAPR-16-0194","article-title":"A Way Forward for Cancer Chemoprevention: Think Local","volume":"10","author":"Bergan","year":"2017","journal-title":"Cancer Prev. Res."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/j.gastro.2019.06.047","article-title":"Chemoprevention of Colorectal Cancer","volume":"158","author":"Katona","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1158\/1055-9965.EPI-15-0085","article-title":"Colorectal Cancer Risk Following Adenoma Removal: A Large Prospective Population-Based Cohort Study","volume":"24","author":"Coleman","year":"2015","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_252","first-page":"6277","article-title":"Current Concepts in Colorectal Cancer Prevention with Cyclooxygenase Inhibitors","volume":"34","author":"Ranger","year":"2014","journal-title":"Anticancer Res."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of Prostaglandin Synthesis as a Mechanism of action for Aspirin-like Drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nat. New Biol."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.31557\/APJCP.2019.20.6.1675","article-title":"Over-Expression of Cyclooxygenase-2 in Colorectal Cancer Patients","volume":"20","author":"Negi","year":"2019","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_255","first-page":"228","article-title":"Correlation of COX-2 Expression in Colorectal Carcinoma with Clinicopathological Features","volume":"33","author":"Venkatachala","year":"2017","journal-title":"Turk. Patoloji Derg."},{"key":"ref_256","first-page":"1047","article-title":"Medication Use and Risk of Proximal Colon Cancer: A Systematic Review of Prospective Studies with Narrative Synthesis and Meta-Analysis","volume":"32","author":"Harewood","year":"2021","journal-title":"Cancer Causes Control"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1001\/jama.2022.3337","article-title":"Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force","volume":"327","author":"Evans","year":"2022","journal-title":"JAMA"},{"key":"ref_258","doi-asserted-by":"crossref","unstructured":"Harris, R.E., Beebe-Donk, J., and Alshafie, G.A. (2008). Similar Reductions in the Risk of Human Colon Cancer by Selective and Nonselective Cyclooxygenase-2 (COX-2) Inhibitors. BMC Cancer, 8.","DOI":"10.1186\/1471-2407-8-237"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"i16","DOI":"10.1093\/rheumatology\/keh104","article-title":"Safety of Anti-Inflammatory Treatment\u2014New Ways of Thinking","volume":"43","author":"Brune","year":"2004","journal-title":"Rheumatology"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/ard.62.6.501","article-title":"Therapeutic Role of Dual Inhibitors of 5-LOX and COX, Selective and Non-Selective Non-Steroidal Anti-Inflammatory Drugs","volume":"62","author":"Lajeunesse","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/bcp.13048","article-title":"Cardiovascular Effects of Cyclooxygenase-2 Inhibitors: A Mechanistic and Clinical Perspective","volume":"82","author":"Patrono","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/carcin\/bgi012","article-title":"Dual Inhibition of 5-LOX and COX-2 Suppresses Colon Cancer Formation Promoted by Cigarette Smoke","volume":"26","author":"Ye","year":"2005","journal-title":"Carcinogenesis"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"37","DOI":"10.15537\/smj.2022.43.1.20210574","article-title":"Celecoxib as an Adjuvant to Chemotherapy for Patients with Metastatic Colorectal Cancer: A Randomized Controlled Clinical Study","volume":"43","author":"Mostafa","year":"2022","journal-title":"Saudi Med. J."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1758834015614530","article-title":"Pharmacologic Resistance in Colorectal Cancer: A Review","volume":"8","author":"Hammond","year":"2016","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1001\/jama.2021.2454","article-title":"Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival among Patients with Stage III Colon Cancer: The CALGB\/SWOG 80702 (Alliance) Randomized Clinical Trial","volume":"325","author":"Meyerhardt","year":"2021","journal-title":"JAMA"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.pharmtox.42.082301.164620","article-title":"COX-2: A Target for Colon Cancer Prevention","volume":"42","author":"Marnett","year":"2002","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1158\/1940-6207.CAPR-11-0107","article-title":"Nonsteroidal Anti-Inflammatory Drug Use and Risk of Adenomatous and Hyperplastic Polyps","volume":"4","author":"Murff","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1158\/0008-5472.CAN-07-6100","article-title":"Genetic Deletion of mPGES-1 Suppresses Intestinal Tumorigenesis","volume":"68","author":"Nakanishi","year":"2008","journal-title":"Cancer Res."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1158\/1940-6207.CAPR-11-0188","article-title":"Selective PGE(2) Suppression Inhibits Colon Carcinogenesis and Modifies Local Mucosal Immunity","volume":"4","author":"Nakanishi","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"ref_270","doi-asserted-by":"crossref","unstructured":"Bergqvist, F., Ossipova, E., Idborg, H., Raouf, J., Checa, A., Englund, K., Englund, P., Khoonsari, P.E., Kultima, K., and Wheelock, C.E. (2019). Inhibition of mPGES-1 or COX-2 Results in Different Proteomic and Lipidomic Profiles in A549 Lung Cancer Cells. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.00636"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"106383","DOI":"10.1016\/j.prostaglandins.2019.106383","article-title":"A Review on mPGES-1 Inhibitors: From Preclinical Studies to Clinical Applications","volume":"147","author":"Bergqvist","year":"2020","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1016\/j.bmcl.2017.06.075","article-title":"Selective Inhibitors of Human mPGES-1 from Structure-Based Computational Screening","volume":"27","author":"Zhou","year":"2017","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_273","doi-asserted-by":"crossref","unstructured":"Yarla, N.S., Madka, V., Pathuri, G., and Rao, C.V. (2020). Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249609"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2147\/JIR.S286110","article-title":"Discovery and Development of a Novel mPGES-1\/5-LOX Dual Inhibitor LFA-9 for Prevention and Treatment of Chronic Inflammatory Diseases","volume":"13","author":"Yarla","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/carcin\/bgm265","article-title":"Licofelone, a Dual COX\/5-LOX Inhibitor, Induces Apoptosis in HCA-7 Colon Cancer Cells through the Mitochondrial Pathway from Its Ability to Affect the Arachidonic Acid","volume":"29","author":"Tavolari","year":"2008","journal-title":"Carcinogenesis"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12079-020-00585-0","article-title":"A Review of Prostanoid Receptors: Expression, Characterization, Regulation, and Mechanism of Action","volume":"15","author":"Biringer","year":"2021","journal-title":"J. Cell Commun. Signal."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/vms3.13","article-title":"Grapiprant: An EP 4 Prostaglandin Receptor Antagonist and novel Therapy for Pain and Inflammation","volume":"2","author":"Rhodes","year":"2016","journal-title":"Vet. Med. Sci."},{"key":"ref_278","first-page":"28","article-title":"Involvement of Prostaglandin E Receptor Subtype EP(4) in Colon Carcinogenesis","volume":"62","author":"Mutoh","year":"2002","journal-title":"Cancer Res."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"9665","DOI":"10.1158\/0008-5472.CAN-06-1271","article-title":"Host and Direct Antitumor Effects and Profound Reduction in Tumor Metastasis with Selective EP4 Receptor Antagonism","volume":"66","author":"Yang","year":"2006","journal-title":"Cancer Res."},{"key":"ref_280","doi-asserted-by":"crossref","unstructured":"Mizuno, R., Kawada, K., and Sakai, Y. (2019). Prostaglandin E2\/EP Signaling in the Tumor Microenvironment of Colorectal Cancer. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20246254"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/24\/12191\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T05:16:55Z","timestamp":1766207815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/24\/12191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":280,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["ijms262412191"],"URL":"https:\/\/doi.org\/10.3390\/ijms262412191","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]}}}